Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,028 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improved survival with vemurafenib in melanoma with BRAF V600E mutation.
Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, Hogg D, Lorigan P, Lebbe C, Jouary T, Schadendorf D, Ribas A, O'Day SJ, Sosman JA, Kirkwood JM, Eggermont AM, Dreno B, Nolop K, Li J, Nelson B, Hou J, Lee RJ, Flaherty KT, McArthur GA; BRIM-3 Study Group. Chapman PB, et al. Among authors: nelson b. N Engl J Med. 2011 Jun 30;364(26):2507-16. doi: 10.1056/NEJMoa1103782. Epub 2011 Jun 5. N Engl J Med. 2011. PMID: 21639808 Free PMC article. Clinical Trial.
Analysis of dermatologic events in vemurafenib-treated patients with melanoma.
Lacouture ME, Duvic M, Hauschild A, Prieto VG, Robert C, Schadendorf D, Kim CC, McCormack CJ, Myskowski PL, Spleiss O, Trunzer K, Su F, Nelson B, Nolop KB, Grippo JF, Lee RJ, Klimek MJ, Troy JL, Joe AK. Lacouture ME, et al. Among authors: nelson b. Oncologist. 2013;18(3):314-22. doi: 10.1634/theoncologist.2012-0333. Epub 2013 Mar 1. Oncologist. 2013. PMID: 23457002 Free PMC article.
Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Outcomes by Prior Number of Regimens.
Perez-Gracia JL, Loriot Y, Rosenberg JE, Powles T, Necchi A, Hussain SA, Morales-Barrera R, Retz MM, Niegisch G, Durán I, Théodore C, Grande E, Shen X, Wang J, Nelson B, Derleth CL, van der Heijden MS. Perez-Gracia JL, et al. Among authors: nelson b. Eur Urol. 2018 Mar;73(3):462-468. doi: 10.1016/j.eururo.2017.11.023. Epub 2017 Dec 20. Eur Urol. 2018. PMID: 29273410 Free PMC article.
Corrigendum re: "Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Outcomes by Prior Number of Regimens" [Eur Urol 2018;73:462-8].
Perez-Gracia JL, Loriot Y, Rosenberg JE, Powles T, Necchi A, Hussain SA, Morales-Barrera R, Retz MM, Niegisch G, Durán I, Théodore C, Grande E, Shen X, Wang J, Nelson B, Derleth CL, van der Heijden MS. Perez-Gracia JL, et al. Among authors: nelson b. Eur Urol. 2019 Mar;75(3):e82-e83. doi: 10.1016/j.eururo.2018.11.032. Epub 2018 Nov 28. Eur Urol. 2019. PMID: 30502102 No abstract available.
Atezolizumab Versus Chemotherapy in Patients with Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: A Long-term Overall Survival and Safety Update from the Phase 3 IMvigor211 Clinical Trial.
van der Heijden MS, Loriot Y, Durán I, Ravaud A, Retz M, Vogelzang NJ, Nelson B, Wang J, Shen X, Powles T. van der Heijden MS, et al. Among authors: nelson b. Eur Urol. 2021 Jul;80(1):7-11. doi: 10.1016/j.eururo.2021.03.024. Epub 2021 Apr 23. Eur Urol. 2021. PMID: 33902955 Clinical Trial.
Interactions between leaf phenological type and functional traits drive variation in isoprene emissions in central Amazon forest trees.
Robin M, Römermann C, Niinemets Ü, Gershenzon J, Huang J, Nelson BW, Taylor TC, de Souza VF, Pinho D, Falcão L, Lacerda C, Duvoisin Júnior S, Schmidt A, Gomes Alves E. Robin M, et al. Among authors: nelson bw. Front Plant Sci. 2024 Dec 24;15:1522606. doi: 10.3389/fpls.2024.1522606. eCollection 2024. Front Plant Sci. 2024. PMID: 39777083 Free PMC article.
The effects of recent stressful life events on outcomes in individuals at clinical high risk for psychosis: results from the longitudinal EU-GEI high-risk study.
See CRZ, Si S, Hedges E, Tognin S, Modinos G, van der Gaag M, de Haan L, Velthorst E, McGorry P, Nelson B, Riecher-Rössler A, Bressan R, Barrantes-Vidal N, Krebs MO, Nordentoft M, Ruhrmann S, Sachs G, Rutten BP, van Os J; EU-GEI High Risk Study; McGuire P, Valmaggia LR, Kempton MJ. See CRZ, et al. Among authors: nelson b. Psychol Med. 2025 Jan 8:1-11. doi: 10.1017/S0033291724003039. Online ahead of print. Psychol Med. 2025. PMID: 39773326
Characterizing the Clinical Trajectory and Predicting Persistence and Deterioration of Attenuated Psychotic Symptoms in Ultra-High-Risk Individuals.
Wannan C, Scott I, Dwyer D, Clark SR, Hartmann S, Ye RR, Amminger GP, Yuen HP, Lavoie S, Markulev C, Schaefer MR, Hartmann JA, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger G, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, Kerr M, Spark J, Wallis N, Polari A, McGorry PD, Nelson B. Wannan C, et al. Among authors: nelson b. Schizophr Bull. 2024 Dec 20:sbae204. doi: 10.1093/schbul/sbae204. Online ahead of print. Schizophr Bull. 2024. PMID: 39707153
3,028 results